Approved Uses

Otezla® (apremilast) is a prescription medicine approved for the treatment of adult patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.

Otezla is a prescription medicine approved for the treatment of adult patients with active psoriatic arthritis.

Otezla is a prescription medicine approved for the treatment of adult patients with oral ulcers associated with Behçet’s Disease.

 
Otezla for moderate to severe
plaque psoriasis
Otezla for psoriatic arthritis
Otezla for oral ulcers
in Behçet’s Disease
SEE MORE

*Certain restrictions apply. *Certain restrictions apply; eligibility not based on income.

APPROVED USES

Otezla® (apremilast) is a prescription medicine approved for the treatment of adult patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.

Otezla is a prescription medicine approved for the treatment of adult patients with active psoriatic arthritis.

Otezla is a prescription medicine approved for the treatment of adult patients with oral ulcers associated with Behçet’s Disease.

IMPORTANT SAFETY INFORMATION

You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.

Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of having diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.

Otezla is associated with an increase in depression. In clinical studies, some patients reported depression, or suicidal behavior while taking Otezla. Some patients stopped taking Otezla due to depression. Before starting Otezla, tell your doctor if you have had feelings of depression, or suicidal thoughts or behavior. Be sure to tell your doctor if any of these symptoms or other mood changes develop or worsen during treatment with Otezla.

Some patients taking Otezla lost body weight. Your doctor should monitor your weight regularly. If unexplained or significant weight loss occurs, your doctor will decide if you should continue taking Otezla.

Some medicines may make Otezla less effective, and should not be taken with Otezla. Tell your doctor about all the medicines you take, including prescription and nonprescription medicines.

Side effects of Otezla include diarrhea, nausea, vomiting, upper respiratory tract infection, runny nose, sneezing, or congestion, abdominal pain, tension headache, and headache. These are not all the possible side effects with Otezla. Ask your doctor about other potential side effects. Tell your doctor about any side effect that bothers you or does not go away.

Tell your doctor if you are pregnant, planning to become pregnant or planning to breastfeed. Otezla has not been studied in pregnant women or in women who are breastfeeding.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-332-1088.

Please click here for Full Prescribing Information for Otezla.

Enroll in the $0 co-pay program

Getting a $0 co-pay card
Did you know the majority of people pay $0* a month for the #1 prescribed branded pill for plaque psoriasis?

Just fill out and submit the form below—if you’re eligible, you’ll be automatically enrolled and your new $0 co-pay card will be immediately available for use.

Prefer to do things over the phone? You can also call 1-844-4OTEZLA (1-844-468-3952) and speak to a SupportPlus™ team member to enroll (available 8 am – 8 pm ET, Monday – Friday).

Sign up for a card

Fill out this form to enroll.

All fields required.

Please correct the fields in red.

  • You are a resident of the United States, Puerto Rico, US Virgin Islands, or Guam
  • You have private, employer-based, or commercial insurance (provided by your employer or directly purchased by you)
  • You do not purchase medications through Medicare, Medicaid, or any other federal or state prescription program
  • You are over the age of 18

    Note: In the event that you’re enrolled in federally funded health insurance without your knowledge, there’s a chance your card could be rejected.

    Which condition are you diagnosed with? Check all that apply.


    By providing my phone number, I consent to Amgen calling and texting me at the phone number(s) I have provided with promotional communications relating to Amgen products and services and/or my condition or treatment. Amgen may use automatic dialing machines or artificial or prerecorded messages to contact me and may leave a voicemail or SMS/text message (standard text messaging rates may apply). I understand that I am not required to provide this consent as a condition of purchasing any goods or services. Reply STOP to cancel SMS messages.

    Amgen’s Patient Authorization

    Uses and Disclosure of Personal Information

    I authorize Amgen and its contractors and business partners (“Amgen”) to use and/or disclose my personal information, including my personal health information, only for the following purposes:

    • To operate, administer, enroll me in, and/or continue my participation in Amgen’s Otezla SupportPlusTM program or any other Amgen-affiliated patient support services and activities related to my condition or treatment (for example, co-pay card programs, reimbursement assistance programs, drug coverage verification, nurse educator services, adherence program and disease management support);
    • To contact, with my permission, my doctor and the rest of my health care team and share with them my health information that may be useful for my care;
    • To provide me with informational and promotional materials relating to Amgen products and services, and/or my condition or treatment; and/or
    • To improve, develop, and evaluate products, services, materials and programs related to my condition or treatment.

    In order for Amgen to provide me with the services and/or programs described above, Amgen needs to collect and use my personal information, including my personal health information. I understand that my personal health information may include any information, in electronic or physical form, in the possession of or derived from a health care provider, health care plan, pharmacy, pharmaceutical company, laboratory and/or their contractor (“Health Care Provider”). This may include select information from or about my medical history and general health, my health care plan benefits, payment limits or restrictions covered by my health care plan policy, and/or my adherence to my treatment.

    I authorize my Health Care Providers to disclose my personal health information to Amgen, and between themselves, as necessary, but only for the purposes stated above in this Authorization. I understand that certain of my Health Care Providers (such as pharmacies and specialty pharmacies) may receive remuneration from Amgen in exchange for disclosing my personal health information and/or for using my information to contact me with communications about Amgen products which have been prescribed to me (for example medication reminder programs) and other patient support services.

    Expiration, Right to Obtain a Copy and Right to Cancel

    I understand that by signing this form, I authorize my Health Care Providers or others who might hold my health information to only release it to Amgen employees, as well as to its contractors and business partners, who are performing the services set forth in this Authorization. I also understand I am authorizing my personal information, including my personal health information, to be used for the purposes described above. I understand and agree that by signing below, I am authorizing those who rely on this Authorization to release my personal health information for the earlier of five (5) years or until my participation in the program ends through my cancellation, unless a shorter time period is required by state law.

    I understand that I can obtain a copy of this Authorization or cancel this Authorization at any time by calling Amgen at 1-844-468-3952 or by writing to PO BOX 13185, La Jolla, California, 92039. If I cancel my consent, I will no longer qualify for the services described. I also understand that if a Health Care Provider is disclosing my personal health information to Amgen on an authorized on-going basis, my cancellation with Amgen will be effective with respect to any such Health Care Providers as soon as they receive notice of my cancellation.

    No Effect on Treatment

    I understand I do not have to sign this Authorization and that my enrollment in any of the services and/or programs described above is entirely voluntary. I understand that Amgen, as well as Health Care Providers, cannot require me, as a condition of having access to medications, prescription drugs, treatment or other care, to sign this Authorization. Federal Law (including HIPAA) requires a signed authorization in order for Amgen to collect this information from my Health Care Providers. I understand I cannot participate in the listed services and/or programs without signing this Authorization or an equivalent authorization with my Health Care Providers.

    Information Received from Health Care Providers

    I understand that once my personal health information has been disclosed to Amgen, federal privacy laws may no longer apply and protect it from further disclosure. Amgen agrees, however, to protect my personal health information by only using and disclosing it as stated in the Authorization or as otherwise allowed or required by law.

    Authorization to Contact

    I understand and consent to Amgen contacting me using the contact information provided in this form to enroll me in, operate, and administer Amgen patient support services and/or programs as described above other than promotional communications by telephone or SMS/text (which I can separately opt-in below). I understand that the operation and administration of certain of these services and/or programs may require that Amgen contact me by telephone or SMS/text.


    By clicking the “I accept” button, I am electronically indicating that I have read and understood Amgen's Patient Authorization (above in its full text), that I am legally authorized to consent and that I am providing my consent as the patient or the patient's legal guardian for Amgen and its contractors and business partners to use and share the personal information I provide for the purposes described within the Patient Authorization. By clicking “Cancel” below, my activation and enrollment into Otezla SupportPlusTM will be discontinued.

    Please verify that you are not a robot.

    Not ready to sign up?
    We can remind you! Simply enter your e-mail below, and choose the date on which you’d like to be reminded.

    Ways to save on treatment

    Regardless of what type of insurance (or lack of insurance) you have, we’re committed to helping you find ways to save on Otezla.

    Private, employer-based, or commercially insured

    The majority of people pay $0 a month for the #1 prescribed branded pill for plaque psoriasis. Wondering if you qualify? Fill out and submit the form above or call 1-844-4OTEZLA.

    Even if you have health insurance through your employer, you’re eligible to pay $0 each month for Otezla.

    Covered by Medicare or MedicaidMedicare or Medicaid

    If you’re covered by Medicare or Medicaid, give Otezla SupportPlus a call at 1-844-4OTEZLA. Our team can talk to you about independent co-pay foundations and state programs that may be able to help you pay for your prescription.

    Uninsured or underinsured

    If you do not have insurance, or are underinsured, our Patient Assistance Program (PAP) may be able to help. To get started, download the PAP form (Spanish version here). Have questions? Call the Patient Assistance Program for Otezla at 1-855-554-9168.

    *Certain restrictions apply; eligibility not based on income, must be 18 years or older. This offer is not valid for persons eligible for reimbursement of this product, in whole or in part under Medicaid, Medicare, or similar state or federal programs. Offer not valid for cash-paying patients. People who are not eligible can call 1-844-4OTEZLA to discuss other financial assistance opportunities.
    Source: Symphony Health Solutions PrescriberSource PatientFocus data, Amgen proprietary methodology. Nov2019–Jan2020. Data include only oral formulations for scripts tagged with a plaque psoriasis indication.

    $name

    We’ve got you covered

    If you’re having issues getting your insurance to cover Otezla, don’t worry. You may be eligible for free medication (up to 3 years)* through the Otezla Bridge Program only if:

    • You have active commercial insurance and are experiencing a delay in covering/accessing Otezla
    • Your commercial insurance does not cover Otezla
    • Your healthcare provider is actively pursuing a prior authorization or any appeals with your insurance company

    Call 1-844-4OTEZLA (1-844-468-3952) for more information.

    *To receive a free bridge supply of Otezla, you must have an on-label diagnosis and be denied or experiencing a delay in obtaining coverage. Federal, State, or similar insurance plans are not eligible for Bridge. Once Otezla is approved by your commercial insurance plan, you will no longer be eligible for the Bridge Program.

    SEE MORE

    *Certain restrictions apply. *Certain restrictions apply; eligibility not based on income.

    APPROVED USES

    Otezla® (apremilast) is a prescription medicine approved for the treatment of adult patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.

    Otezla is a prescription medicine approved for the treatment of adult patients with active psoriatic arthritis.

    Otezla is a prescription medicine approved for the treatment of adult patients with oral ulcers associated with Behçet’s Disease.

    IMPORTANT SAFETY INFORMATION

    You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.

    Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of having diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.

    Otezla is associated with an increase in depression. In clinical studies, some patients reported depression, or suicidal behavior while taking Otezla. Some patients stopped taking Otezla due to depression. Before starting Otezla, tell your doctor if you have had feelings of depression, or suicidal thoughts or behavior. Be sure to tell your doctor if any of these symptoms or other mood changes develop or worsen during treatment with Otezla.

    Some patients taking Otezla lost body weight. Your doctor should monitor your weight regularly. If unexplained or significant weight loss occurs, your doctor will decide if you should continue taking Otezla.

    Some medicines may make Otezla less effective, and should not be taken with Otezla. Tell your doctor about all the medicines you take, including prescription and nonprescription medicines.

    Side effects of Otezla include diarrhea, nausea, vomiting, upper respiratory tract infection, runny nose, sneezing, or congestion, abdominal pain, tension headache, and headache. These are not all the possible side effects with Otezla. Ask your doctor about other potential side effects. Tell your doctor about any side effect that bothers you or does not go away.

    Tell your doctor if you are pregnant, planning to become pregnant or planning to breastfeed. Otezla has not been studied in pregnant women or in women who are breastfeeding.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-332-1088.

    Please click here for Full Prescribing Information.

    Important Safety Information

    See more

    You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.

    Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of having diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.

    $name

    Sign up for support

    $name

    Information about paying for Otezla

    $name

    Track your progress with the free Otezla app

     

    You are now leaving otezla.com and going to Facebook

    The content of the linked site is the sole responsibility of the site provider. Amgen Corporation does not control or endorse this third-party website.

    Click "OK" to proceed or "CANCEL" to return to otezla.com.

    You are now leaving otezla.com and going to Instagram

    The content of the linked site is the sole responsibility of the site provider. Amgen Corporation does not control or endorse this third-party website.

    Click "OK" to proceed or "CANCEL" to return to otezla.com.

    You are now leaving otezla.com and going to Youtube

    The content of the linked site is the sole responsibility of the site provider. Amgen Corporation does not control or endorse this third-party website.

    Click "OK" to proceed or "CANCEL" to return to otezla.com.

    You are now leaving otezla.com and going to Amgen.com

    Are you sure you want to do this?

    You are now leaving otezla.com and going to Amgen’s “Contact Us” page

    Are you sure you want to do this?

    You are now leaving otezla.com and going to www.fda.gov/medwatch

    The content of the linked site is the sole responsibility of the site provider. Amgen Inc. does not control or endorse this third-party website.

    Click "OK" to proceed or "CANCEL" to return to otezla.com.